JP Stock MarketDetailed Quotes

4506 Sumitomo Pharma

Watchlist
  • 608
  • +29+5.01%
20min DelayMarket Closed Dec 16 15:30 JST
241.92BMarket Cap-0.77P/E (Static)

Sumitomo Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Total revenue
19.80%90.68B
-43.38%314.56B
-16.53%79.53B
-41.56%82.39B
-51.73%76.96B
-52.66%75.69B
-0.80%555.54B
-25.54%95.28B
1.90%140.98B
-1.92%159.41B
Cost of revenue
14.85%34.95B
-29.25%126.58B
-14.73%33.39B
-29.96%32.87B
-36.11%29.89B
-33.93%30.43B
13.87%178.92B
-0.35%39.15B
14.50%46.93B
21.91%46.79B
Gross profit
23.14%55.73B
-50.09%187.98B
-17.79%46.14B
-47.35%49.52B
-58.21%47.06B
-60.24%45.26B
-6.52%376.63B
-36.70%56.13B
-3.40%94.05B
-9.29%112.63B
Operating expense
-39.24%58.83B
19.67%542.84B
145.61%283.26B
-2.59%80.77B
-47.49%81.99B
-2.40%96.82B
32.37%453.6B
33.07%115.33B
-4.37%82.91B
83.95%156.16B
Selling and administrative expenses
-39.43%45.36B
15.06%429.54B
183.83%237.98B
-29.48%57.51B
-54.72%59.15B
-3.10%74.89B
49.88%373.32B
39.62%83.85B
26.73%81.56B
108.62%130.62B
-General and administrative expense
-39.43%45.36B
15.06%429.54B
183.83%237.98B
-29.48%57.51B
-54.72%59.15B
-3.10%74.89B
49.88%373.32B
39.62%83.85B
26.73%81.56B
108.62%130.62B
Research and development costs
-52.87%13.12B
-14.58%112.64B
-30.20%38.99B
-10.47%23.29B
-11.92%22.51B
14.01%27.84B
38.94%131.86B
105.97%55.86B
17.85%26.02B
9.80%25.56B
Other operating expenses
51.54%641M
382.33%8.13B
999.33%6.61B
51.72%663M
20.27%439M
49.47%423M
53.83%1.69B
171.95%601M
-1.35%437M
137.01%365M
Total other operating income
-95.39%292M
-85.98%7.47B
-98.72%320M
-97.20%702M
-71.79%110M
127.22%6.34B
2,113.47%53.26B
3,326.89%24.98B
14,662.35%25.1B
-66.18%390M
Operating profit
93.98%-3.11B
-360.98%-354.86B
-300.52%-237.11B
-380.54%-31.25B
19.75%-34.93B
-452.86%-51.57B
-227.80%-76.98B
-3,051.25%-59.2B
4.52%11.14B
-210.86%-43.53B
Net non-operating interest income (expenses)
-1.01%20.31B
9.24%31.75B
111.12%19.19B
40.57%-17.82B
-45.10%9.86B
-35.88%20.52B
27.86%29.06B
-40.87%9.09B
-629.59%-29.98B
778.76%17.95B
Non-operating interest income
4.78%22.33B
11.81%36.02B
116.66%20.73B
----
-43.11%10.71B
-35.17%21.32B
24.99%32.22B
-40.68%9.57B
----
625.76%18.82B
Non-operating interest expense
153.13%2.03B
35.39%4.28B
221.46%1.54B
-40.57%17.82B
-1.73%851M
-9.40%800M
3.57%3.16B
-37.01%480M
3,753.47%29.98B
57.45%866M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
Income before tax
155.40%17.2B
-574.28%-323.11B
-334.87%-217.92B
-160.40%-49.06B
1.96%-25.08B
-166.62%-31.05B
-157.76%-47.92B
-388.36%-50.11B
-215.47%-18.84B
-161.91%-25.58B
Income tax
-83.78%1.27B
-116.77%-8.19B
-248.07%-20.69B
161.66%899M
-78.61%3.8B
-57.83%7.81B
15.19%48.79B
16.84%13.98B
-113.11%-1.46B
46.41%17.76B
Net income
141.01%15.94B
-225.63%-314.93B
-207.75%-197.23B
-187.41%-49.96B
33.37%-28.87B
-238.34%-38.86B
-338.21%-96.71B
-1,283.07%-64.09B
-434.57%-17.38B
-248.51%-43.33B
Net income continuous operations
141.01%15.94B
-225.63%-314.93B
-207.75%-197.23B
-187.41%-49.96B
33.37%-28.87B
-238.34%-38.86B
-338.21%-96.71B
-1,283.07%-64.09B
-434.57%-17.38B
-248.51%-43.33B
Noncontrolling interests
66.67%-1M
100.18%40M
100.38%31M
100.06%4M
100.04%2M
99.90%-3M
-40.40%-22.2B
-74.19%-8.08B
-30.81%-6.17B
-100.28%-4.94B
Net income attributable to the company
141.01%15.94B
-322.71%-314.97B
-252.19%-197.26B
-345.38%-49.97B
24.78%-28.88B
-224.92%-38.86B
-232.08%-74.51B
-657.09%-56.01B
-213.22%-11.22B
-221.31%-38.39B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
6M
0
0
0
0
Net income attributable to common stockholders
141.01%15.94B
-322.71%-314.97B
-252.19%-197.26B
-345.38%-49.97B
24.78%-28.88B
-224.94%-38.87B
-232.08%-74.51B
-657.09%-56.01B
-213.22%-11.22B
-221.31%-38.39B
Gross dividend payment
Basic earnings per share
141.00%40.11
-322.71%-792.79
-252.18%-496.51
-345.36%-125.77
24.79%-72.68
-224.93%-97.82
-232.09%-187.55
-657.23%-140.98
-213.23%-28.24
-221.30%-96.63
Diluted earnings per share
141.00%40.11
-322.71%-792.79
-252.19%-496.5154
-345.36%-125.77
24.79%-72.68
-224.93%-97.82
-232.09%-187.55
-657.23%-140.98
-213.23%-28.24
-221.30%-96.63
Dividend per share
0
0
0
0
0
0
-25.00%21
-50.00%7
0
0.00%14
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Jun 30, 2024 (FY)Mar 31, 2024 (Q4)Mar 31, 2024 (Q3)Dec 31, 2023 (Q2)Sep 30, 2023 (Q1)Jun 30, 2023 (FY)Mar 31, 2023 (Q4)Mar 31, 2023 (Q3)Dec 31, 2022 (Q2)Sep 30, 2022
Total revenue 19.80%90.68B -43.38%314.56B -16.53%79.53B -41.56%82.39B -51.73%76.96B -52.66%75.69B -0.80%555.54B -25.54%95.28B 1.90%140.98B -1.92%159.41B
Cost of revenue 14.85%34.95B -29.25%126.58B -14.73%33.39B -29.96%32.87B -36.11%29.89B -33.93%30.43B 13.87%178.92B -0.35%39.15B 14.50%46.93B 21.91%46.79B
Gross profit 23.14%55.73B -50.09%187.98B -17.79%46.14B -47.35%49.52B -58.21%47.06B -60.24%45.26B -6.52%376.63B -36.70%56.13B -3.40%94.05B -9.29%112.63B
Operating expense -39.24%58.83B 19.67%542.84B 145.61%283.26B -2.59%80.77B -47.49%81.99B -2.40%96.82B 32.37%453.6B 33.07%115.33B -4.37%82.91B 83.95%156.16B
Selling and administrative expenses -39.43%45.36B 15.06%429.54B 183.83%237.98B -29.48%57.51B -54.72%59.15B -3.10%74.89B 49.88%373.32B 39.62%83.85B 26.73%81.56B 108.62%130.62B
-General and administrative expense -39.43%45.36B 15.06%429.54B 183.83%237.98B -29.48%57.51B -54.72%59.15B -3.10%74.89B 49.88%373.32B 39.62%83.85B 26.73%81.56B 108.62%130.62B
Research and development costs -52.87%13.12B -14.58%112.64B -30.20%38.99B -10.47%23.29B -11.92%22.51B 14.01%27.84B 38.94%131.86B 105.97%55.86B 17.85%26.02B 9.80%25.56B
Other operating expenses 51.54%641M 382.33%8.13B 999.33%6.61B 51.72%663M 20.27%439M 49.47%423M 53.83%1.69B 171.95%601M -1.35%437M 137.01%365M
Total other operating income -95.39%292M -85.98%7.47B -98.72%320M -97.20%702M -71.79%110M 127.22%6.34B 2,113.47%53.26B 3,326.89%24.98B 14,662.35%25.1B -66.18%390M
Operating profit 93.98%-3.11B -360.98%-354.86B -300.52%-237.11B -380.54%-31.25B 19.75%-34.93B -452.86%-51.57B -227.80%-76.98B -3,051.25%-59.2B 4.52%11.14B -210.86%-43.53B
Net non-operating interest income (expenses) -1.01%20.31B 9.24%31.75B 111.12%19.19B 40.57%-17.82B -45.10%9.86B -35.88%20.52B 27.86%29.06B -40.87%9.09B -629.59%-29.98B 778.76%17.95B
Non-operating interest income 4.78%22.33B 11.81%36.02B 116.66%20.73B ---- -43.11%10.71B -35.17%21.32B 24.99%32.22B -40.68%9.57B ---- 625.76%18.82B
Non-operating interest expense 153.13%2.03B 35.39%4.28B 221.46%1.54B -40.57%17.82B -1.73%851M -9.40%800M 3.57%3.16B -37.01%480M 3,753.47%29.98B 57.45%866M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
Income before tax 155.40%17.2B -574.28%-323.11B -334.87%-217.92B -160.40%-49.06B 1.96%-25.08B -166.62%-31.05B -157.76%-47.92B -388.36%-50.11B -215.47%-18.84B -161.91%-25.58B
Income tax -83.78%1.27B -116.77%-8.19B -248.07%-20.69B 161.66%899M -78.61%3.8B -57.83%7.81B 15.19%48.79B 16.84%13.98B -113.11%-1.46B 46.41%17.76B
Net income 141.01%15.94B -225.63%-314.93B -207.75%-197.23B -187.41%-49.96B 33.37%-28.87B -238.34%-38.86B -338.21%-96.71B -1,283.07%-64.09B -434.57%-17.38B -248.51%-43.33B
Net income continuous operations 141.01%15.94B -225.63%-314.93B -207.75%-197.23B -187.41%-49.96B 33.37%-28.87B -238.34%-38.86B -338.21%-96.71B -1,283.07%-64.09B -434.57%-17.38B -248.51%-43.33B
Noncontrolling interests 66.67%-1M 100.18%40M 100.38%31M 100.06%4M 100.04%2M 99.90%-3M -40.40%-22.2B -74.19%-8.08B -30.81%-6.17B -100.28%-4.94B
Net income attributable to the company 141.01%15.94B -322.71%-314.97B -252.19%-197.26B -345.38%-49.97B 24.78%-28.88B -224.92%-38.86B -232.08%-74.51B -657.09%-56.01B -213.22%-11.22B -221.31%-38.39B
Preferred stock dividends
Other under preferred stock dividend 0 0 0 0 0 6M 0 0 0 0
Net income attributable to common stockholders 141.01%15.94B -322.71%-314.97B -252.19%-197.26B -345.38%-49.97B 24.78%-28.88B -224.94%-38.87B -232.08%-74.51B -657.09%-56.01B -213.22%-11.22B -221.31%-38.39B
Gross dividend payment
Basic earnings per share 141.00%40.11 -322.71%-792.79 -252.18%-496.51 -345.36%-125.77 24.79%-72.68 -224.93%-97.82 -232.09%-187.55 -657.23%-140.98 -213.23%-28.24 -221.30%-96.63
Diluted earnings per share 141.00%40.11 -322.71%-792.79 -252.19%-496.5154 -345.36%-125.77 24.79%-72.68 -224.93%-97.82 -232.09%-187.55 -657.23%-140.98 -213.23%-28.24 -221.30%-96.63
Dividend per share 0 0 0 0 0 0 -25.00%21 -50.00%7 0 0.00%14
Currency Unit JPY JPY JPY JPY JPY JPY JPY JPY JPY JPY
Accounting Standards NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP
Heat List
JP
Overall
Symbol
Price
% Chg

No Data